An Alu insertion in compound heterozygosity with a microduplication in GNPTAB gene underlies Mucolipidosis II

Research output: Contribution to journalArticle

Abstract

Mucolipidosis type II (ML II) is a fatal, autosomal recessive, lysosomal storage disorder characterized by severe clinical and radiologic features. ML II results from mutations in alpha and beta subunits, encoded by the GlcNAc-1-phosphotransferase gene (GNPTAB). Most of the 40 different GNPTAB mutations reported so far are insertions and deletions predicting diverse types of aberrant proteins. Alu mobile elements have however never been involved in these events up to now. The Italian ML II patient of our study showed an Alu retrotrasposition in GNPTAB exon 5. The Alu insertion mutation (NM_024312.3:c.555_556insHSU14569) generated a transcript with a skipping of the target exon 5 and a frameshift p.S122fs, causing a premature translation termination codon at position 123. This insertion mutation was found in compound heterozygosity with the frameshift p.S887KfsX33, resulting from a new mono-nucleotide duplication (c.2659dupA) that occurred in GNPTAB exon 13. A possible involvement of cis-splicing elements having an exonic location, such as exon enhancers (ESEs), is discussed as mechanism that led to the production of the aberrant mRNA splicing.

Original languageEnglish
Pages (from-to)129-133
Number of pages5
JournalMolecular Genetics and Metabolism
Volume93
Issue number2
DOIs
Publication statusPublished - Feb 2008

Fingerprint

Mucolipidoses
Exons
Genes
Insertional Mutagenesis
Alu Elements
Mutation
Nonsense Codon
Phosphotransferases
Nucleotides
Messenger RNA
Proteins

Keywords

  • Exon enhancers
  • Exon skipping
  • Exonic Alu insertion
  • GlcNAc-1-phosphotransferase
  • GNPTAB
  • I-cell disease
  • Microduplication
  • Mucolipidosis type II

ASJC Scopus subject areas

  • Biochemistry
  • Genetics
  • Endocrinology, Diabetes and Metabolism

Cite this

@article{39ef7803282640c685473995b71916c0,
title = "An Alu insertion in compound heterozygosity with a microduplication in GNPTAB gene underlies Mucolipidosis II",
abstract = "Mucolipidosis type II (ML II) is a fatal, autosomal recessive, lysosomal storage disorder characterized by severe clinical and radiologic features. ML II results from mutations in alpha and beta subunits, encoded by the GlcNAc-1-phosphotransferase gene (GNPTAB). Most of the 40 different GNPTAB mutations reported so far are insertions and deletions predicting diverse types of aberrant proteins. Alu mobile elements have however never been involved in these events up to now. The Italian ML II patient of our study showed an Alu retrotrasposition in GNPTAB exon 5. The Alu insertion mutation (NM_024312.3:c.555_556insHSU14569) generated a transcript with a skipping of the target exon 5 and a frameshift p.S122fs, causing a premature translation termination codon at position 123. This insertion mutation was found in compound heterozygosity with the frameshift p.S887KfsX33, resulting from a new mono-nucleotide duplication (c.2659dupA) that occurred in GNPTAB exon 13. A possible involvement of cis-splicing elements having an exonic location, such as exon enhancers (ESEs), is discussed as mechanism that led to the production of the aberrant mRNA splicing.",
keywords = "Exon enhancers, Exon skipping, Exonic Alu insertion, GlcNAc-1-phosphotransferase, GNPTAB, I-cell disease, Microduplication, Mucolipidosis type II",
author = "B. Tappino and S. Regis and F. Corsolini and M. Filocamo",
year = "2008",
month = "2",
doi = "10.1016/j.ymgme.2007.09.010",
language = "English",
volume = "93",
pages = "129--133",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - An Alu insertion in compound heterozygosity with a microduplication in GNPTAB gene underlies Mucolipidosis II

AU - Tappino, B.

AU - Regis, S.

AU - Corsolini, F.

AU - Filocamo, M.

PY - 2008/2

Y1 - 2008/2

N2 - Mucolipidosis type II (ML II) is a fatal, autosomal recessive, lysosomal storage disorder characterized by severe clinical and radiologic features. ML II results from mutations in alpha and beta subunits, encoded by the GlcNAc-1-phosphotransferase gene (GNPTAB). Most of the 40 different GNPTAB mutations reported so far are insertions and deletions predicting diverse types of aberrant proteins. Alu mobile elements have however never been involved in these events up to now. The Italian ML II patient of our study showed an Alu retrotrasposition in GNPTAB exon 5. The Alu insertion mutation (NM_024312.3:c.555_556insHSU14569) generated a transcript with a skipping of the target exon 5 and a frameshift p.S122fs, causing a premature translation termination codon at position 123. This insertion mutation was found in compound heterozygosity with the frameshift p.S887KfsX33, resulting from a new mono-nucleotide duplication (c.2659dupA) that occurred in GNPTAB exon 13. A possible involvement of cis-splicing elements having an exonic location, such as exon enhancers (ESEs), is discussed as mechanism that led to the production of the aberrant mRNA splicing.

AB - Mucolipidosis type II (ML II) is a fatal, autosomal recessive, lysosomal storage disorder characterized by severe clinical and radiologic features. ML II results from mutations in alpha and beta subunits, encoded by the GlcNAc-1-phosphotransferase gene (GNPTAB). Most of the 40 different GNPTAB mutations reported so far are insertions and deletions predicting diverse types of aberrant proteins. Alu mobile elements have however never been involved in these events up to now. The Italian ML II patient of our study showed an Alu retrotrasposition in GNPTAB exon 5. The Alu insertion mutation (NM_024312.3:c.555_556insHSU14569) generated a transcript with a skipping of the target exon 5 and a frameshift p.S122fs, causing a premature translation termination codon at position 123. This insertion mutation was found in compound heterozygosity with the frameshift p.S887KfsX33, resulting from a new mono-nucleotide duplication (c.2659dupA) that occurred in GNPTAB exon 13. A possible involvement of cis-splicing elements having an exonic location, such as exon enhancers (ESEs), is discussed as mechanism that led to the production of the aberrant mRNA splicing.

KW - Exon enhancers

KW - Exon skipping

KW - Exonic Alu insertion

KW - GlcNAc-1-phosphotransferase

KW - GNPTAB

KW - I-cell disease

KW - Microduplication

KW - Mucolipidosis type II

UR - http://www.scopus.com/inward/record.url?scp=38049066748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38049066748&partnerID=8YFLogxK

U2 - 10.1016/j.ymgme.2007.09.010

DO - 10.1016/j.ymgme.2007.09.010

M3 - Article

C2 - 17964840

AN - SCOPUS:38049066748

VL - 93

SP - 129

EP - 133

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 2

ER -